CRVS logo

Corvus Pharmaceuticals, Inc. (CRVS)

Profile

Full Name

Corvus Pharmaceuticals, Inc.

Ticker

NASDAQ: CRVS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 23, 2016

Indexes

Not included

Website

https://www.corvuspharma.com

Employees

31

Key Details

Price

$5.93(-3.89%)

Market cap

$441.87M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.02(-82.14% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.93
    CRVS price is $5.93

    30-Day Relative Volume

    1.04
    CRVS 30-day relative volume is 1.04

    Price Performance

    Price Most recent change

    -3.89%
    CRVS price was down -3.89% on Sep 10, 2025

    Price YTD change

    +10.84%
    CRVS price is up +10.84% since January 1st

    Price 1-year change

    +27.94%
    CRVS price is up +27.94% year-on-year

    Price 3-year change

    +493%
    CRVS price is up +493% over the past 3 years

    Price Range

    Price All-time high

    $22.14
    CRVS price is currently -73.21% below its historical high of $22.14

    Price 3-year low

    $0.61
    CRVS price is currently +876.94% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $441.87M
    CRVS market capitalization is $441.87 million

    Market cap 3-year change

    +849.16%
    CRVS market capitalization is up +849.16% over the past 3 years

    Market cap All-time high

    $605.30M
    CRVS market capitalization is currently -27.00% below its historical high of $605.30 million

    Market cap sector rank

    62.1%
    CRVS market capitalization is higher than 62.1% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +19.12%
    CRVS shares outstanding is up +19.12% year-on-year

    Shares Outstanding 3-Year Change

    +60.06%
    CRVS shares outstanding is up +60.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.21
    CRVS beta is 1.21

    200-day SMA

    $4.75
    CRVS price is currently +24.87% above its 200-day simple moving average

    50-day SMA

    $4.78
    CRVS price is currently +24.07% above its 50-day simple moving average

    RSI

    62.47
    CRVS 14-day relative strength index is 62.47

    Volume

    1.04
    CRVS 30-day relative volume is 1.04

    ATR

    $0.34
    CRVS average true range is $0.34

    10-day Historical Volatility

    65.01%
    CRVS 10-day historical volatility is 65.01%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CRVS annual revenue is $0.00

    Revenue Analysts estimate

    $620.00K
    CRVS annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    CRVS annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.73%
    CRVS annual revenue is higher than 28.73% of companies in Healthcare sector

    EPS

    EPS

    -$1.02
    CRVS annual earnings per share is -$1.02

    EPS Analysts estimate

    -$0.14
    CRVS annual earnings per share is currently +655.56% higher than the consensus analysts' forecast

    EPS 1-year change

    -82.14%
    CRVS annual earnings per share is down -82.14% year-on-year

    EPS Sector rank

    51.72%
    CRVS annual earnings per share is higher than 51.72% of companies in Healthcare sector

    Profit

    Gross profit

    -$85.00K
    CRVS annual gross profit is -$85.00 thousand

    Gross margin

    -
    CRVS annual gross profit margin value is unknown

    Operating profit

    -$27.55M
    CRVS annual operating income is -$27.55 million

    Operating margin

    -
    CRVS annual operating profit margin value is unknown

    Net income

    -$62.29M
    CRVS annual net profit is -$62.29 million

    Net margin

    -
    CRVS annual net profit margin value is unknown

    Expenses

    Total expenses

    $62.29M
    CRVS annual total expenses is $62.29 million

    Operating expenses

    $27.46M
    CRVS annual total operating expenses is $27.46 million

    Cost of goods sold

    $85.00K
    CRVS annual cost of goods sold is $85.00 thousand

    Selling, general & administrative expenses

    $0.00
    CRVS annual SGA is $0.00

    Depreciation and amortization

    $85.00K
    CRVS annual depreciation & amortization is $85.00 thousand

    Interest expense

    $0.00
    CRVS annual interest expense is $0.00

    Income tax

    $0.00
    CRVS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$27.55M
    CRVS annual earnings before interest & taxes is -$27.55 million

    EBITDA

    -$27.46M
    CRVS annual EBITDA is -$27.46 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $68.91M
    CRVS annual total assets is $68.91 million

    Non current assets

    $14.50M
    CRVS annual long term assets is $14.50 million

    Current assets

    $54.41M
    CRVS annual total current assets is $54.41 million

    Cash and cash equivalents

    $8.74M
    CRVS annual cash & cash equivalents is $8.74 million

    Accounts receivable

    $75.00K
    CRVS annual accounts receivable is $75.00 thousand

    Inventory

    $0.00
    CRVS annual inventory is $0.00

    Liabilities

    Total liabilities

    $36.34M
    CRVS annual total liabilities is $36.34 million

    Long term liabilities

    $937.00K
    CRVS annual total long term liabilities is $937.00 thousand

    Current liabilities

    $35.40M
    CRVS annual total current liabilities is $35.40 million

    Accounts payable

    $2.58M
    CRVS annual accounts payable is $2.58 million

    Debt

    Total debt

    $1.12M
    CRVS annual total debt is $1.12 million

    Total debt 1-year change

    -18.34%
    CRVS annual total debt is down -18.34% year-on-year

    Long term debt

    $937.00K
    CRVS annual long term debt is $937.00 thousand

    Short term debt

    $185.00K
    CRVS annual short term debt is $185.00 thousand

    Equity & Capital

    Shareholders equity

    $32.57M
    CRVS annual stockholders equity is $32.57 million

    Book value

    $32.57M
    CRVS annual book value is $32.57 million

    Retained earnings

    -$397.01M
    CRVS annual retained earnings is -$397.01 million

    Working capital

    $19.00M
    CRVS annual working capital is $19.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$25.42M
    CRVS annual cash flow from operations is -$25.42 million

    Cash from operations 1-year change

    -6.22%
    CRVS annual cash flow from operations is down -6.22% year-on-year

    Cash from investing

    -$27.48M
    CRVS annual cash flow from investing activities is -$27.48 million

    Cash from investing 1-year change

    -276.85%
    CRVS annual cash flow from investing activities is down -276.85% year-on-year

    Cash from financing

    $49.03M
    CRVS annual cash flow from financing activities is $49.03 million

    Cash from financing 1-year change

    +524.16%
    CRVS annual cash flow from financing activities is up +524.16% year-on-year

    CAPEX

    CAPEX

    $0.00
    CRVS annual capital expenditures is $0.00

    CAPEX 1-year change

    -100%
    CRVS annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free cash flow

    -$25.42M
    CRVS annual free cash flow is -$25.42 million

    Free cash flow 1-year change

    -6.07%
    CRVS annual free cash flow is down -6.07% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CRVS annual gross profit margin value is unknown

    Operating margin

    -
    CRVS annual operating profit margin value is unknown

    Net margin

    -
    CRVS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -108.85%
    CRVS annual return on assets is -108.85%

    ROE

    -174.85%
    CRVS annual return on equity is -174.85%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CRVS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CRVS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    5.51
    CRVS price to book ratio is 5.51

    PB ratio Sector rank

    80.12%
    CRVS price to book ratio is higher than 80.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CRVS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CRVS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $368.54M
    CRVS enterprise value is $368.54 million

    Enterprise value Sector rank

    62.89%
    CRVS enterprise value is higher than 62.89% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -10.40
    CRVS EV/EBITDA is -10.40

    EV/EBITDA Sector rank

    12.98%
    CRVS EV/EBITDA is higher than 12.98% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.54
    CRVS annual current ratio is 1.54

    Quick ratio

    1.54
    CRVS annual quick ratio is 1.54

    Leverage

    Debt to equity

    0.03
    CRVS annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    CRVS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CRVS piotroski f-score value is unknown

    Altman Z-Score

    -1.76
    CRVS altman z-score is -1.76

    Analyst ratings

    Recent major analysts updates

    May 20, 25 Mizuho
    Outperform
    May 9, 25 Oppenheimer
    Outperform
    Mar 26, 25 Oppenheimer
    Outperform
    Mar 26, 25 HC Wainwright & Co.
    Buy
    Jan 14, 25 HC Wainwright & Co.
    Buy
    Jan 2, 25 HC Wainwright & Co.
    Buy
    Nov 13, 24 Oppenheimer
    Outperform
    Sep 16, 24 Ladenburg Thalmann
    Buy
    May 7, 24 Oppenheimer
    Outperform
    Apr 1, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with CRVS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Corvus Pharmaceuticals, Inc.?
    • Does Corvus Pharmaceuticals, Inc. pay dividends?
    • What sector is Corvus Pharmaceuticals, Inc. in?
    • What industry is Corvus Pharmaceuticals, Inc. in?
    • What country is Corvus Pharmaceuticals, Inc. based in?
    • When did Corvus Pharmaceuticals, Inc. go public?
    • Is Corvus Pharmaceuticals, Inc. in the S&P 500?
    • Is Corvus Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Corvus Pharmaceuticals, Inc. in the Dow Jones?
    • When was Corvus Pharmaceuticals, Inc.'s last earnings report?
    • When does Corvus Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Corvus Pharmaceuticals, Inc.?

    The ticker symbol for Corvus Pharmaceuticals, Inc. is NASDAQ:CRVS

    Does Corvus Pharmaceuticals, Inc. pay dividends?

    No, Corvus Pharmaceuticals, Inc. does not pay dividends

    What sector is Corvus Pharmaceuticals, Inc. in?

    Corvus Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Corvus Pharmaceuticals, Inc. in?

    Corvus Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Corvus Pharmaceuticals, Inc. based in?

    Corvus Pharmaceuticals, Inc. is headquartered in United States

    When did Corvus Pharmaceuticals, Inc. go public?

    Corvus Pharmaceuticals, Inc.'s initial public offering (IPO) was on March 23, 2016

    Is Corvus Pharmaceuticals, Inc. in the S&P 500?

    No, Corvus Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Corvus Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Corvus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Corvus Pharmaceuticals, Inc. in the Dow Jones?

    No, Corvus Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Corvus Pharmaceuticals, Inc.'s last earnings report?

    Corvus Pharmaceuticals, Inc.'s most recent earnings report was on August 7, 2025

    When does Corvus Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Corvus Pharmaceuticals, Inc. is November 11, 2025
    On this page